Evidence map›Paper›PMID 29374858›Full record

ReviewCurrent HIV/AIDS reports2018

Tools for Visualizing HIV in Cure Research.

Julia Niessl, Amy E Baxter, Daniel E Kaufmann

Open access · greenAbstract readReview
In one paragraph

Review in Current HIV/AIDS reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.7field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Diagnostic applications of microsphere-based flow cytometry: A review.Experimental biology and medicine (Maywood, N.J.) · 2022
    Review
  2. Review
  3. Roadmap toward the 10 ps time-of-flight PET challenge.Physics in medicine and biology · 2020
    Article
  4. Article
  5. Ethical issues in HIV remission trials.Current opinion in HIV and AIDS · 2018
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Julia NiesslCentre de Recherche du Centre Hospitalier de l'Université de Montréal (CRCHUM), 900, St-Denis Street, Room 09-456, Montreal, QC, H2X 0A9, Canada.
Amy E BaxterCentre de Recherche du Centre Hospitalier de l'Université de Montréal (CRCHUM), 900, St-Denis Street, Room 09-456, Montreal, QC, H2X 0A9, Canada.
Daniel E KaufmannCentre de Recherche du Centre Hospitalier de l'Université de Montréal (CRCHUM), 900, St-Denis Street, Room 09-456, Montreal, QC, H2X 0A9, Canada. daniel.kaufmann@umontreal.ca.
Centre Hospitalier de l’Université de Montréal · CAInternational AIDS Vaccine Initiative · US

Funding

Support Component D/Vaccine Discovery, Concept to ClinicUM1AI100663 · NIAID · SCRIPPS RESEARCH INSTITUTE, THE · PI AHMED, RAFI · 2012 to 2018
$131.5M
Immunoregulatory networks and HIV pathogenesisR01HL092565 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI KAUFMANN, DANIEL E · 2007 to 2015
$3.4M
CIHR 152536CIHR 377124NHLBI NIH HHS R01 HL092565NIAID NIH HHS UM1 AI100663
6 · The paper itself

Abstract

purpose of reviewThe long-lived HIV reservoir remains a major obstacle for an HIV cure. Current techniques to analyze this reservoir are generally population-based. We highlight recent developments in methods visualizing HIV, which offer a different, complementary view, and provide indispensable information for cure strategy development. RECENT

findingsRecent advances in fluorescence in situ hybridization techniques enabled key developments in reservoir visualization. Flow cytometric detection of HIV mRNAs, concurrently with proteins, provides a high-throughput approach to study the reservoir on a single-cell level. On a tissue level, key spatial information can be obtained detecting viral RNA and DNA in situ by fluorescence microscopy. At total-body level, advancements in non-invasive immuno-positron emission tomography (PET) detection of HIV proteins may allow an encompassing view of HIV reservoir sites. HIV imaging approaches provide important, complementary information regarding the size, phenotype, and localization of the HIV reservoir. Visualizing the reservoir may contribute to the design, assessment, and monitoring of HIV cure strategies in vitro and in vivo.

Indexed as

Flow CytometryHIV-1HIV InfectionsHuman Immunodeficiency Virus ProteinsHumansIn Situ Hybridization, FluorescencePositron-Emission TomographyRNA, ViralVirus LatencyHuman Immunodeficiency Virus ProteinsRNA, ViralFlow cytometryHIV cureIn situ hybridization (ISH)MicroscopyPositron emission tomography (PET)RNA flowViral reservoir

Identifiers

PMID29374858
PMCPMC5878129
OpenAlexW2791462071

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.